Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

July 31, 2007

Conditions
Diabetic Foot Ulcers
Interventions
DRUG

ATG002 (study drug)

Trial Locations (13)

16365

NewBridge Medical Research, Warren

21117

Crossroads Research, Inc., Owings Mills

27599

University of North Carolina at Chapel Hill, Chapel Hill

30058

Ankle and Foot Specialists of Atlanta, Lithonia

33136

University of Miami, Miami

35209

SeniorCare, Alabama Geriatric Specialists, Homewood

53215

Aurora Health Care / Lukes Medical Center, Milwaukee

85050

Hope Research Institute, Phoenix

85723

Southern Arizona VA Health Care System, Tucson

92103

University of San Diego Wound Treatment and Research Center, San Diego

94546

Center for Clinical Research, Castro Valley

98902

Central Washington Podiatry Service, Yakima

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CoMentis

INDUSTRY

NCT00316537 - Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter